Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular transcription and translation machinery encompasses the integrated system of enzymes, proteins, and RNA molecules responsible for converting genetic information from DNA into functional proteins [1][2]. This complex includes RNA polymerases, which catalyze the synthesis of RNA from a DNA template (transcription), and ribosomes, which facilitate the assembly of amino acids into polypeptide chains based on mRNA sequences (translation) [1][2]. In disease states, such as cancer, this machinery is often hijacked or upregulated to support rapid cell proliferation, while many pathogens rely on the host's machinery for their own replication [3][4]. Consequently, components of this system are major targets for therapeutic intervention; for instance, many antibiotics target bacterial ribosomes to inhibit protein synthesis, and certain chemotherapeutics inhibit RNA polymerases to arrest tumor growth [5][6]. However, targeting these fundamental processes in humans poses significant challenges due to the potential for severe systemic toxicity and off-target effects on essential cellular functions [7]. References: [1] Alberts B, et al. Molecular Biology of the Cell. 6th edition. Garland Science; 2014. [2] National Human Genome Research Institute (NHGRI). "Transcription" and "Translation". genome.gov. [3] Ruggero D. "Translational control in cancer development." Nature Reviews Cancer. 2013;13(6):413-425. [4] Walsh D, Mohr I. "Viral strategies to take over the host translation machinery." Nature Reviews Microbiology. 2011;9(12):860-881. [5] Wilson DN. "Ribosome-targeting antibiotics and mechanisms of bacterial resistance." Nature Reviews Microbiology. 2014;12(1):35-48. [6] Villicaña C, et al. "RNA Polymerase II as a Therapeutic Target in Cancer." Cells. 2020;9(11):2473. [7] Hori S, et al. "Safety and toxicity of targeting the protein synthesis machinery." Expert Opinion on Drug Discovery. 2018;13(12):1153-1165.
Inhibition of RNA polymerase activity, interference with ribosomal subunit assembly or function, blocking of tRNA binding, and inhibition of peptide bond formation or translocation [5][6].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular transcription and translation machinery.